has_Ingredient has_MoA has_PE drug associated with AE in adult drug associated with AE in pediatric used to treat disease Increased Adhesion Factor Production [PE] Decreased Vascular Permeability [PE] infliximab [Chemical/Ingredient] I [Preparations] INFLIXIMAB http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103772s5301lbl.pdf <VANDF_Record>50.6^3519^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>3519</VA_IEN> 191831 INFLIXIMAB infliximab Ingredient B72HH48FLU C0666743 4021126 N0000148580 <VANDF_Record>50.416^3797^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>3797</VA_IEN> C273255 Active Tumor Necrosis Factor alpha Receptor Blocking Activity [MoA] ankylosing spondylitis rheumatoid arthritis ulcerative colitis Crohn's disease psoriasis psoriatic arthritis flushing AE nasal congestion AE pharyngitis AE rhinorrhea AE sneezing AE upper respiratory tract infection AE fever AE infection AE headache AE cough AE abdominal pain AE viral infection AE bacterial infection AE anemia AE fracture AE leukopenia AE neutropenia AE